FDA Cancels Emergency Use of Hydroxychloroquine: ‘Unlikely to Be Effective’ Against Coronavirus
The U.S. Food and Drug Administration (FDA), citing the latest science and data, rescinded its emergency use authorization (EUA) for chloroquine and hydroxychloroquine, the anti-malaria drugs touted by President Donald Trump and some doctors to combat the Chinese coronavirus.